Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial

This article has no abstract
Epistemonikos ID: b75a43d8b78b13867a7edd3213983507a7d87d31
First added on: Feb 13, 2025